Sector revisions Sun Pharmaceutical Industries Ltd.

Equities

Market Closed - NSE India S.E. Other stock markets 04:35:09 05/06/2026 pm IST			5-day change	1st Jan Change
1,782.20 ^INR	+0.12%		-0.94%	+3.63%

26/05	Sun Pharmaceutical Industries Limited Presents Updated Results from Locally Advanced Cutaneous Squamous Cell Carcinoma Expansion Cohort from Pivotal CK-301-101 Trial of UNLOXCYT (Cosibelimab-Ipdl) at ASCO 2026 Annual Meeting	CI
26/05	Sun Pharma to present long-term follow-up data on Unloxcyt	RE

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
SUN PHARMACEUTICAL INDUSTRIES LTD.					34
OTSUKA HOLDINGS CO., LTD.					12
CIPLA LIMITED					37
ZYDUS LIFESCIENCES LIMITED					30
KRKA, D. D.					6
GEDEON RICHTER					7
ONO PHARMACEUTICAL CO., LTD.					12
GLENMARK PHARMACEUTICALS LIMITED					10
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.				-	-
HANMI PHARM. CO., LTD.					15
AJANTA PHARMA LIMITED					14
ASPEN PHARMACARE HOLDINGS LIMITED					4
SIMCERE PHARMACEUTICAL GROUP LIMITED					5
JAMJOOM PHARMACEUTICALS FACTORY COMPANY					3
ASTRA INDUSTRIAL GROUP COMPANY				-	1
HAW PAR CORPORATION LIMITED		-	-	-	1
SUNSHINE LAKE PHARMA CO., LTD.	-	-		-	-
APICHOPE PHARMACEUTICAL GROUP CO., LTD.				-	-
Average					13
Weighted average by Cap.					20